Treatment of prostate cancer with radiotherapy: should the entire seminal vesicles be included in the clinical target volume? (Q34960066)

5 August 2017

Treatment of prostate cancer with radiotherapy: should the entire seminal vesicles be included in the clinical target volume? (English)

1 reference

5 August 2017

0 references

1 reference

Larry Kestin

1

1 reference

5 August 2017

Neal Goldstein

2

1 reference

5 August 2017

Frank Vicini

3

1 reference

5 August 2017

Di Yan

4

1 reference

5 August 2017

Howard Korman

5

1 reference

5 August 2017

Alvaro Martinez

6

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

International Journal of Radiation Oncology Biology Physics

5 August 2017

1 reference

5 August 2017

54

1 reference

5 August 2017

686-697

1 reference

5 August 2017

3

1 reference

Defining a dose-response relationship with radiotherapy for prostate cancer: is more really better?

5 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903011-0

7 January 2021

The effect of dose on local control of prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903011-0

7 January 2021

Dose selection for prostate cancer patients based on dose comparison and dose response studies

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903011-0

7 January 2021

Defining the optimal radiation dose with three-dimensional conformal radiation therapy for patients with nonmetastatic prostate carcinoma by using recursive partitioning techniques.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903011-0

7 January 2021

Higher than standard radiation doses (> or =72 Gy) with or without androgen deprivation in the treatment of localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903011-0

7 January 2021

Importance of high radiation doses (72 Gy or greater) in the treatment of stage T1-T3 adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903011-0

7 January 2021

External beam radiotherapy dose response characteristics of 1127 men with prostate cancer treated in the PSA era

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903011-0

7 January 2021

Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903011-0

7 January 2021

Survival advantage from higher-dose radiation therapy for clinically localized prostate cancer treated on the Radiation Therapy Oncology Group trials

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903011-0

7 January 2021

Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903011-0

7 January 2021

Matched-pair analysis of conformal high-dose-rate brachytherapy boost versus external-beam radiation therapy alone for locally advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903011-0

7 January 2021

A dose-response study for I-125 prostate implants

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903011-0

7 January 2021

Long-term results of retropubic permanent 125iodine implantation of the prostate for clinically localized prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903011-0

7 January 2021

Indications for and the significance of seminal vesicle irradiation during 3D conformal radiotherapy for localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903011-0

7 January 2021

Indications for excluding the seminal vesicles when treating clinically localized prostatic adenocarcinoma with radiotherapy alone

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903011-0

7 January 2021

Revision of treatment planning for carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903011-0

7 January 2021

Improvement in dose escalation using the process of adaptive radiotherapy combined with three-dimensional conformal or intensity-modulated beams for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903011-0

7 January 2021

An off-line strategy for constructing a patient-specific planning target volume in adaptive treatment process for prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903011-0

7 January 2021

Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903011-0

7 January 2021

Correlation of clinical stage, serum prostatic acid phosphatase and preoperative Gleason grade with final pathological stage in 275 patients with clinically localized adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903011-0

7 January 2021

The mechanisms and prognostic significance of seminal vesicle involvement by prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903011-0

7 January 2021

Prediction of capsular perforation and seminal vesicle invasion in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903011-0

7 January 2021

Equivalent 5-year bNED in select prostate cancer patients managed with surgery or radiation therapy despite exclusion of the seminal vesicles from the CTV

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903011-0

7 January 2021

Correlation of pretherapy prostate cancer characteristics with seminal vesicle invasion in radical prostatectomy specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903011-0

7 January 2021

Analysis of prostate and seminal vesicle motion: implications for treatment planning

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903011-0

7 January 2021

Should the seminal vesicles be resected during radical prostatectomy?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903011-0

7 January 2021

103Pd brachytherapy and external beam irradiation for clinically localized, high-risk prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903011-0

7 January 2021

High-dose rate interstitial with external beam irradiation for localized prostate cancer--results of a prospective trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903011-0

7 January 2021

Long-term outcome after elective irradiation of the pelvic lymphatics and local dose escalation using high-dose-rate brachytherapy for locally advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903011-0

7 January 2021

Three-dimensional computed tomography-guided monotherapeutic pararectal brachytherapy of prostate cancer with seminal vesicle invasion

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903011-0

7 January 2021

Interim report of image-guided conformal high-dose-rate brachytherapy for patients with unfavorable prostate cancer: the William Beaumont phase II dose-escalating trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903011-0

7 January 2021

High dose-rate afterloading 192Iridium prostate brachytherapy: feasibility report.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903011-0

7 January 2021

Modern prostate brachytherapy. Prostate specific antigen results in 219 patients with up to 12 years of observed follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903011-0

7 January 2021

Does prostate brachytherapy treat the seminal vesicles? A dose-volume histogram analysis of seminal vesicles in patients undergoing combined PD-103 prostate implantation and external beam irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903011-0

7 January 2021

High dose combination radiotherapy for the treatment of localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903011-0

7 January 2021

Conformal prostate brachytherapy: initial experience of a phase I/II dose-escalating trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903011-0

7 January 2021

Can extraprostatic extension be treated by prostate brachytherapy? An analysis based on postimplant dosimetry

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903011-0

7 January 2021

Pathogenesis and biological significance of seminal vesicle invasion in prostatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903011-0

7 January 2021

Radical prostatectomy: is complete resection of the seminal vesicles really necessary?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903011-0

7 January 2021

Adenocarcinoma of the prostate invading the seminal vesicle: prognostic stratification based on pathologic parameters

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903011-0

7 January 2021

Computed tomography in definitive radiotherapy of prostatic carcinoma, part 2: definition of target volume

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903011-0

7 January 2021

Adjuvant radiotherapy for pathologic stage T3/4 adenocarcinoma of the prostate: ten-year update

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903011-0

7 January 2021

Adjuvant irradiation after prostatectomy for carcinoma of the prostate with positive surgical margins

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903011-0

7 January 2021

Radical Prostatectomy in the Management of Carcinoma of the Prostate: Probable Causes of Some Therapeutic Failures

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903011-0

7 January 2021

The incidence and significance of seminal vesicle invasion in patients with adenocarcinoma of the prostate.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903011-0

7 January 2021

Intra- and inter-observer variability in contouring prostate and seminal vesicles: implications for conformal treatment planning.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903011-0

7 January 2021

10.1016/S0360-3016(02)03011-0

Identifiers

DOI

1 reference

release_5j4rbye3jjbzbki2uu2lzj4t3y

5 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5j4rbye3jjbzbki2uu2lzj4t3y

24 November 2022

mapped directly with Wikidata item

1 reference